Sustained-release subdermal estradiol implants: A new alternative in estrogen replacement therapy

American Journal of Obstetrics and Gynecology

Volumn 169, Issue 5, 1993, Pages 1248-1254

  Suhonen, Satu P ^a,c   Allonen, Hannu O ^b   Lähteenmäki, Pekka ^c  

^a Helsinki City Maternity Hospital   (Finland)

^b Oy Leiras Finland Ab   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Estradiol implants; parenteral hormone replacement therapy; polydimethylsiloxane; sustained release

Indexed keywords

DIMETICONE; ESTRADIOL; ESTRONE; FOLLITROPIN; LEVONORGESTREL; SEX HORMONE BINDING GLOBULIN; UNCLASSIFIED DRUG; YESTRADERM 50;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MENOPAUSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SUSTAINED RELEASE PREPARATION; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; AGED; DELAYED-ACTION PREPARATIONS; DRUG IMPLANTS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MIDDLE AGED; OSMOLAR CONCENTRATION; SEX HORMONE-BINDING GLOBULIN; SKIN;

EID: 0027141912     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(93)90291-P     Document Type: Article

References (25)

1. Postmenopausal estrogen therapy and cardiovascular disease
2. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program follow-up study
3. Long-term prevention of postmenopausal osteoporosis by oestrogen
4. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause
5. Use of hormone replacement therapy in 1976–1989 by 45–64 year old Finnish women
6. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol
7. Subdermal estradiol pellets following hysterectomy and oophorectomy
8. Hormone implants and tachyphylaxis
9. Silastic implants releasing estrone in the treatment of climacteric complaints
10. Postmenopausal estrogen replacement therapy with subcutaneous estradiol implants
11. Effects of estrogens and progestogens on the biochemistry and morphology of the postmenopausal endometrium
12. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices
13. Intrauterine release of levonorgestrel — a new way of adding progestogen in hormone replacement therapy
14. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: comparison with conventional oral estrogens used for hormone replacement
15. Monitoring the LH surge by ultrarapid and highly sensitive immunofluorometric assay
16. Influence of oral contraceptives on immediate postabortal pituitary-ovarian function
17. Optimal use of postmenopausal hormone replacement
18. A randomized comparison of nonoral estradiol delivery in postmenopausal women
19. The effects of hormone implants in serum lipoproteins and steroid hormones in bilaterally oophorectomised women
20. Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women
21. Continuous combined conjugated estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis
22. Sustained intrauterine release of levonorgestrel over five years
23. Biologic effects of transdermal estradiol
24. Effects of d-norgestrel induced decreases in sex hormone binding globulin capacity on the d-norgestrel levels in plasma